← Dashboard
Stock
ISRG
Intuitive Surgical, Inc.Health CareHealth Care EquipmentLatest close $4409 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
9
27 funds tracked
Ever held
16
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 13, 2013May 11, 2017Nov 13, 2020Nov 13, 2025
Now
9
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2013 | 52Q | $43 | $440 | +927% |
| Coatue Management re-entered | Q3 2013 | 52Q | $43 | $440 | +926% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $471 | $440 | -7% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $471 | $440 | -7% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $471 | $440 | -7% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $471 | $440 | -7% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $471 | $440 | -7% |
| Point72 Asset Management | Q3 2024(8Q snapshot) | 7Q | $471 | $440 | -7% |
| Renaissance Technologies re-entered | Q4 2024(8Q snapshot) | 6Q | $537 | $440 | -18% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Soros Fund Management | Q3 2024 | Q4 2024 | → $538 | +14% |
| Viking Global Investors 2× in & out | Q4 2023 | Q4 2024 | → $538 | +84% |
| Maverick Capital 6× in & out | Q3 2023 | Q2 2024 | → $399 | +31% |
| D1 Capital Partners | Q4 2022 | Q1 2023 | → $241 | -7% |
| Glenview Capital | Q2 2020 | Q3 2020 | → $228 | +32% |
| Duquesne Family Office 2× in & out | Q4 2019 | Q1 2020 | → $201 | +9% |
| Lone Pine Capital | Q3 2013 | Q4 2013 | → $44 | +3% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at INTUITIVE SURGICAL INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
4
Filings · last 90d
18
Total on file
628
Recent SEC buffer
Most recent
Jun 2, 2026
30d / 90d windows measured from Jun 2, 2026 — the most recent Form 4 on file — not from today.
- Form 40002106898-26-000015Jun 2, 2026
- Form 40002010300-26-000017May 22, 2026
- Form 40002010300-26-000015May 20, 2026
- Form 40001561733-26-000010May 11, 2026
- Form 40001280628-26-000012May 1, 2026
- Form 40001854171-26-000002Apr 30, 2026
- Form 40001223017-26-000002Apr 30, 2026
- Form 40001416180-26-000004Apr 30, 2026
- Form 40001781750-26-000004Apr 30, 2026
- Form 40001689392-26-000006Apr 30, 2026
- Form 40001388397-26-000002Apr 30, 2026
- Form 40001224994-26-000002Apr 30, 2026
- Form 40001249557-26-000002Apr 30, 2026
- Form 40001277620-26-000002Apr 30, 2026
- Form 40001781750-26-000002Apr 29, 2026
Showing 15 of 628 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · Intuitive Surgical, Inc.Annual figures sourced directly from Intuitive Surgical, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$10.06B
FY2025+21% YoY
Net income
$2.86B
FY2025+23% YoY
EPS (diluted)
$7.87
FY2025+23% YoY
Free cash flow(?)
$3.03B
FY2025+25% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for INTUITIVE SURGICAL INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 28, 2026
- 8-KMaterial eventMay 4, 2026
- 10-QQuarterly reportApr 22, 2026
- 8-KMaterial eventApr 21, 2026
- DEF 14AProxy statementMar 13, 2026
- 8-KMaterial eventMar 2, 2026
- 10-KAnnual reportFeb 3, 2026
- 8-KMaterial eventJan 22, 2026
- 8-KMaterial eventJan 14, 2026
- 8-KMaterial eventDec 18, 2025
- 10-QQuarterly reportOct 22, 2025
- 8-KMaterial eventOct 21, 2025
- 10-QQuarterly reportJul 23, 2025
- 8-KMaterial eventJul 22, 2025
- 8-KMaterial eventMay 15, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q4 2025 | open | $566 | $440 | -22% |
| Renaissance Technologies | Q4 2024 | Q3 2025 | $537 | $482 | -10% |
| Citadel Advisors | Q3 2024 | open | $471 | $440 | -7% |
| Soros Fund Management | Q3 2024 | Q4 2024 | $471 | $538 | +14% |
| Two Sigma Investments | Q3 2024 | open | $471 | $440 | -7% |
| D.E. Shaw | Q3 2024 | open | $471 | $440 | -7% |
| AQR Capital Management | Q3 2024 | open | $471 | $440 | -7% |
| Millennium Management | Q3 2024 | open | $471 | $440 | -7% |
| Point72 Asset Management | Q3 2024 | open | $471 | $440 | -7% |
| Coatue Management | Q4 2023 | open | $292 | $402 | +38% |
| Viking Global Investors | Q4 2023 | Q4 2024 | $292 | $538 | +84% |
| Maverick Capital | Q3 2023 | Q2 2024 | $305 | $399 | +31% |
| D1 Capital Partners | Q4 2022 | Q1 2023 | $259 | $241 | -7% |
| Maverick Capital | Q4 2022 | Q1 2023 | $259 | $241 | -7% |
| Maverick Capital | Q4 2020 | Q1 2022 | $253 | $281 | +11% |
| Bridgewater Associates | Q4 2020 | open | $251 | $402 | +60% |
| Glenview Capital | Q2 2020 | Q3 2020 | $173 | $228 | +32% |
| Duquesne Family Office | Q4 2019 | Q1 2020 | $185 | $201 | +9% |
| Bridgewater Associates | Q4 2019 | Q1 2020 | $184 | $200 | +9% |
| Coatue Management | Q3 2019 | Q3 2020 | $167 | $228 | +37% |
| Duquesne Family Office | Q1 2019 | Q3 2019 | $179 | $167 | -7% |
| Maverick Capital | Q3 2017 | Q4 2018 | $107 | $166 | +55% |
| Maverick Capital | Q4 2016 | Q2 2017 | $69 | $95 | +36% |
| Bridgewater Associates | Q4 2016 | Q2 2017 | $72 | $94 | +30% |
| Bridgewater Associates | Q3 2015 | Q3 2016 | $59 | $77 | +31% |
| Bridgewater Associates | Q4 2014 | Q2 2015 | $57 | $56 | -2% |
| Maverick Capital | Q1 2014 | Q2 2014 | $49 | $40 | -17% |
| Lone Pine Capital | Q3 2013 | Q4 2013 | $43 | $44 | +3% |
| Coatue Management | Q3 2013 | Q1 2014 | $43 | $49 | +14% |
| Viking Global Investors | Q3 2013 | Q1 2014 | $43 | $49 | +14% |
| Bridgewater Associates | Q3 2013 | Q3 2014 | $43 | $50 | +17% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.